News & Media: 2017

Mar 24, 2017

PHE Authors Awarded 2017 JMCP Award for Excellence

Congratulations to PHE authors Joanna MacEwan, Jason Shafrin, and Darius Lakdawalla who along with co-authors Felicia Forma, Ainslie Hatch and Jean-Pierre Lindenmayer have been awarded the 2017 JMCP Award for Excellence.

The JMCP Award for Excellence is annual award recognizing a single articl ...

Mar 15, 2017

Jena in Harvard Business Review: Higher U.S. Physician Spending Doesn’t Lead to Better Outcomes

In the latest edition of the Harvard Business Review, Precision scientific advisor Anupam Jena along with co-author Yusuke Tsugawa focus on new resaerch showing that higher U.S. physician spending does not lead to better patient outcomes.

To read the complete article, please click here.

Mar 9, 2017

Maclean and Jansen Make the Case for Evidence Synthesis in Clinical Leader

In a new article for Clinical Leader, PHE's Ross Maclean and Jeroen Jansen explain how evidence synthesis can reduce the guesswork of clinical trial design.

To read the complete article, please click here.

Mar 3, 2017

Lakdawalla and Malani Author Two-Part Series on ACA in The Conversation

In a new two-part series featured in The Conversation, PHE's Darius Lakdawalla and co-author Anup Malani provide an ACA primer, as well as look at the landscape of health care reform going forward.

In Part One, Lakdawalla and Malani examine the provisions of the Affordable Care Act, focusing o ...

Feb 20, 2017

"Value of Hope" Study of Patient and Physician Preferences Published in Value in Health

The "Value of Hope" study, examining patient and physician preferences for durable survival, was recently published in a special issue of Value in Health-- focusing on value assessment frameworks.

To read the complete study by PHE authors Jason Shafrin, Taylor Schwartz, John Romley, et al, plea ...

Feb 10, 2017

Shafrin in eyeforpharma: Value-based Pricing’s Time Has Come, and It’s Here to Stay

In "The Price of Everything and the Value of Nothing," PHE Senior Research Economist Jason Shafrin talks prices, politics, and the problem of monopolies with eyeforpharma’s Hugh Gosling.

To read the complete article, please click here.

Feb 9, 2017

Precision To Have Prominent Presence at AMCP Annual Meeting 2017

AMCP is coming to Denver March 27th -30th, and Precision is looking forward to the chance to show off our capabilities and experts with a booth presence, three presentations, four posters and more!

Look for us on the exhibitor floor in Booth 312, and check below for complete information on all ...

Feb 2, 2017

Neumann Discusses Cures Act and New FDA Draft Guidance on Communication

In his latest Health Affairs blog posting, PHE Scientific Advisor Peter Neumann and co-author Elle Pope examine Section 3037 of the Cures Act and new FDA draft guidance, which indicate that drug companies will have expanded flexibility to communicate proactively with payors and formulary committ ...

Jan 31, 2017

PHE Team Author New Study on Medicare Part D Price Controls

In "The Long-Term Impact of Price Controls in Medicare Part D," a new scientific paper recently published in Forum for Health Economics and Policy, PHE authors Gigi Moreno, Emma van Eijndhoven, Jennifer Benner and Jeffrey Sullivan examine the potential impact over time of government price settin ...

Jan 19, 2017

PHE's Thorlund Named to List of Top 1% Most Cited Researchers in the World

Precision Health Economics is proud to congratulate Kristian Thorlund, Vice President, Health Analytics, for being named by Clarivate Analytics to their list of "Highly Cited Researchers," representing the top 1% of the most cited researchers in the world. The list is based on the Essential Scie ...

Jan 19, 2017

Peter Neumann in New England Journal of Medicine: Cost-Effectiveness 2.0 -- Poised for a Second Act?

PHE Scientific Advisor Peter Neumann, along with co-author Gillian Sanders, offers a new perspective on cost-effectiveness analysis, just published in the New England Journal of Medicine. Neumann and Sanders provide an overview of recent work, and argue that cost-effectiveness analysis should be ...

Jan 9, 2017

Philipson in Forbes: Is Disneyland the Future of Personalized Medicine?

In Tomas Philipson's latest Forbes.com commentary, he wonders whether the pricing system used by Disneyland and other amusement parks is a concept applicable to personalized medicine.

To read the complete commentary, please click here.

Jan 5, 2017

Jason Shafrin's Blog Named One of the Top 100 Economics Blogs of 2016

Precision Health Economics Senior Research Economist Jason Shafrin's blog, "Healthcare Economist," has been named as one of the top 100 economics blogs of 2016 by Intelligent Economist. The editors write: "His blog is filled with unbiased and research driven critiques of today’s healthcare is ...

Jan 4, 2017

PHE's Anupam Jena Named One of the 60 Most Powerful People in Healthcare for 2016

Precision Health Economics is proud to announce that Scientific Advisor Anupam Jena, MD has been named by Becker's Hospital Review as one of the 60 most powerful people in healthcare in 2016, joining other influential leaders such as Robert Califf, Frances Collins, David Feinberg, Bill & Melinda ...

Jan 3, 2017

Jason Shafrin Interviewed in The Journal of Healthcare Contracting

PHE Senior Research Economist Jason Shafrin discusses the need for and mission of the Innovation and Value Initiative, as well as the keys to its success in the latest edition of The Journal of Healthcare Contracting. "If we find a research topic that life sciences, payers, providers are all beh ...